United Biomedical
Biotechnology, 25 Davids Dr, Hauppauge, New York, 11788, United States, 11-50 Employees
Phone Number: 16*********
Who is UNITED BIOMEDICAL
United Biomedical, Inc (UBI) is a privately held multinational biopharmaceutical company dedicated to the discovery, development and commercialization of immunotherapeutics and vaccines f...
Read More
-
Headquarters: 25 Davids Dr, Hauppauge, New York, 11788, United States
-
Date Founded: 1985
-
Employees: 11-50
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8071
Does something look wrong? Fix it. | View contact records from UNITED BIOMEDICAL
United Biomedical Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding United Biomedical
Answer: United Biomedical's headquarters are located at 25 Davids Dr, Hauppauge, New York, 11788, United States
Answer: United Biomedical's phone number is 16*********
Answer: United Biomedical's official website is https://unitedbiomedical.com
Answer: United Biomedical's revenue is $25 Million to $50 Million
Answer: United Biomedical's SIC: 8071
Answer: United Biomedical has 11-50 employees
Answer: United Biomedical is in Biotechnology
Answer: United Biomedical contact info: Phone number: 16********* Website: https://unitedbiomedical.com
Answer: United Biomedical, Inc (UBI) is a privately held multinational biopharmaceutical company dedicated to the discovery, development and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases. Our product pipeline is filled with our new line of synthetic peptide-based biologicals for the treatment and prevention of Alzheimers Disease, AIDS, and Allergy, along with a portfolio of animal health diseases. These products are based on our proprietary designer peptides, vaccine formulation systems, and methods to manufacture therapeutic monoclonal antibodies. Our platform technologies are also being used to develop a line of biosimilar versions of widely used protein and antibody drugs whose patents are about to expire. UBIs proprietary designer peptide technology has been used to produce a line of blood screening diagnostics and the first successfully commercialized synthetic peptide vaccine. Additional revenue streams are generated from pharmaceutical contract manufacturing by our subsidiary UBI-Asia and various sponsorships in product development.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month